Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) EBIT (2024 - 2025)

Beta Bionics' EBIT history spans 2 years, with the latest figure at -$16.1 million for Q4 2025.

  • For Q4 2025, EBIT fell 23.68% year-over-year to -$16.1 million; the TTM value through Dec 2025 reached -$71.7 million, down 58.41%, while the annual FY2025 figure was -$71.7 million, 58.41% down from the prior year.
  • EBIT for Q4 2025 was -$16.1 million at Beta Bionics, up from -$17.0 million in the prior quarter.
  • Across five years, EBIT topped out at -$9.5 million in Q1 2024 and bottomed at -$19.9 million in Q2 2025.